Senior insider sale
Chief Executive Officer at MINERALYS THERAPEUTICS, INC. — senior position signals high conviction
$2.92M
106.97K shares
What this filing means
CONGLETON JON plans to sell 106.97K shares of MINERALYS THERAPEUTICS, INC. valued at approximately $2.92M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/13/2026ACC: 0001964306-26-000202
DirectorOfficer· Chief Executive Officer
Since Feb 2026
106.97K
Shares to sell
$2.92M
Approx. market value
15.73K
Acquired (3 months)
1
Planned
2 completed
Securities Acquired — Last 3 Months1
Vesting of restricted share unit award
Granted as part of issuer equity compensation plan
4/10/2026
15.73KTotal acquired15.73K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/10/2026 | Vesting of restricted share unit award Granted as part of issuer equity compensation plan | 15.73K | — |
| Total | 15.73K | ||
Planned & Completed Dispositions3
Completed
—Completed
Units to sell
75K
Market value
$1.97M
3/31/2026
—Completed
Units to sell
16.24K
Market value
$529.6K
1/12/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
15.73K
Market value
$422.0K
4/13/2026
Total
Units
106.97K
Value
$2.92M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/31/2026 | 75K | $1.97M | — | Completed |
1/12/2026 | 16.24K | $529.6K | — | Completed |
| Planned — Approximate Date | ||||
4/13/2026 | 15.73K | $422.0K | NASDAQ | Planned |
| Total | 106.97K | $2.92M | ||